1. Haga H, Yamada R, Izumi H, Shinoda Y, Kawahata I, Miyachi H and Fukunaga K. Novel Fatty Acid-Binding Protein 3 Ligand Inhibits Dopaminergic Neuronal Death and Improves Motor and Cognitive Impairments in Parkinson's Disease Model Mice. Pharmacol. Biochem. Behav. 2020, 191, 172891, doi: 10.1016/j.pbb.2020.172891.
2. Kawahata I and Fukunaga K. Degradation of Tyrosine Hydroxylase by the Ubiquitin-Proteasome System in the Pathogenesis of Parkinson's Disease and Dopa-Responsive Dystonia. Int. J. Mol. Sci. 2020, 21(11), 3779, doi: 10.3390/ijms21113779.
3. Yabuki Y, Liu J, Kawahata I, Izumi H, Shinoda Y, Koga K, Ueno S, Shioda N and Fukunaga K. Anti-Epileptic Effects of FABP3 Ligand MF1 through the Benzodiazepine Recognition Site of the GABAA Receptor. Int. J. Mol. Sci. 2020, 21(15), 5525, doi: 10.3390/ijms21155525.
4. Shinoda Y, Wang Y, Yamamoto T, Miyachi H and Fukunaga K. Analysis of binding affinity and docking of novel fatty acid-binding protein (FABP) ligands. J. Pharmacol. Sci. 2020, 143, 264-71, doi: 10.1016/j.jphs.2020.05.005.
5. Kagawa Y, Umaru BA, Shima H, Ito R, Zama R, Islam A, Kanno S, Yasui A, Sato S, Jozaki K, Shil SK, Miyazaki H, Kobayashi S, Yamamoto Y, Kogo H, Shimamoto-Mitsuyama C, Sugawara A, Sugino N, Kanamori M, Tominaga T, Yoshikawa T, Fukunaga K, Igarashi K and Owada Y. FABP7 Regulates Acetyl-CoA Metabolism Through the Interaction with ACLY in the Nucleus of Astrocytes. Mol. Neurobiol. 2020, 57(12), 4891-910, doi: 10.1007/s12035-020-02057-3.
6. Cheng A, Kawahata I, Fukunaga K. Fatty Acid Binding Protein 5 Mediates Cell Death by Psychosine Exposure through Mitochondrial Macropores Formation in Oligodendrocytes. Biomedicines. 2020, 8(12), 635, doi: 10.3390/biomedicines8120635.
7. Matsuo K, Yabuki Y, Melki R, Bousset L, Owada Y, Fukunaga K. Crucial Role of FABP3 in αSyn-Induced Reduction of Septal GABAergic Neurons and Cognitive Decline in Mice. Int J Mol Sci. 2021, 22(1), 400, doi: 10.3390/ijms22010400.
8. Wang Y, Shinoda Y, Cheng A, Kawahata I, Fukunaga K. Epidermal Fatty Acid-Binding Protein 5 (FABP5) Involvement in Alpha-Synuclein-Induced Mitochondrial Injury Under Oxidative Stress. Biomedicines. 2021, 9(2), 110, doi: 10.3390/biomedicines9020110.
9. Kawahata I, Sekimori T, Wang H, Wang Y, Sasaoka T, Bousset L, Melki R, Mizobata T, Kawata Y, Fukunaga K. Dopamine D2 Long Receptors Are Critical for Caveolae-Mediated α-Synuclein Uptake in Cultured Dopaminergic Neurons. Biomedicines. 2021, 9(1), 49, doi: 10.3390/biomedicines9010049.
10. Matsuo K, Kawahata I, Melki R, Bousset L, Owada Y, Fukunaga K. Suppression of α-synuclein propagation after intrastriatal injection in FABP3 null mice. Brain Res. 2021, 1760, 147383, doi: 10.1016/j.brainres.2021.147383.